Cellyan Biotechnology Co., Ltd
HKPD - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$78.46M
Close$
$0.06
97.3% downside
Current Fair Value
97.3% downsideOvervalued by 97.3% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $78.46 Million |
|---|---|
| Enterprise Value | $79.50 Million |
| Earnings per Share | $-0.05 |
| Beta | 2.23 |
| Outstanding Shares | 35,992,911 |
Return
| Return on Equity | -12.14% |
|---|---|
| Return on Assets | -9.05% |
| Return on Invested Capital | -8.44% |
Valuation & Multiples
| P/E Ratio | -4.59 |
|---|---|
| PEG | -9.04 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.36 |
| Enterprise Value to EBIT | -97.59 |
| Enterprise Value to Net Income | -69 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.13 |
Revenue Sources
No data
Institutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.68%▲ 0.42% |
|---|---|
| Total Invested | $105,779▲ 198.39% |
| Investors Holding | 6▲ 2.00% |
About Cellyan Biotechnology Co., Ltd
27 employees
CEO: Chenyu Liang
Cellyan Biotechnology Co., Ltd, an investment holding entity, primarily operates within the over-the-counter (OTC) pharmaceutical sector, serving markets across Hong Kong and mainland China. The company's services encompass the internati...